Skip to main content
. 2018 Oct 31;38(44):9375–9382. doi: 10.1523/JNEUROSCI.1666-18.2018

Figure 1.

Figure 1.

Targeted therapies for PD: from genetics to the clinic. Discovery of genes implicated in PD and subsequent understanding of their physiopathological roles provide the foundation for these genetic-based therapeutic approaches. Large natural history studies, novel biomarker discovery, and disease modeling can help design clinical trials targeting specific patient populations and suitable endpoints.